Dialysis Like Therapeutics (DLT)

Post Date

February 8th 2011

Application Due Date

April 1st 2011

Important Dates: Posting Date: February 8, 2011 Proposer’s Day Date: February 23, 2011 in Arlington, VA Full Proposal Due Date: April 1, 2011

Funding Opportunity Number

DARPA-BAA-11-30

CFDA Number(s)

12.910

Funding Instrument Type(s)

Cooperative Agreement
Grant
Other

Funding Activity Categories

Science and Technology and other Research and Development

Eligibility Categories

Unrestricted

Funding

• Award Range:

  $0 - $0

Grant Description

DARPA is soliciting innovative research proposals to manage the life-threatening blood infection known as sepsis. The goal of the Dialysis Like Therapeutics (DLT) program is to develop a portable device capable of controlling relevant components in the entire blood volume on clinically relevant time scales. Reaching this goal is expected to require significant advances in sensing, complex fluid manipulation, separation of components from these fluids, and mathematical descriptions capable of providing predictive control over the closed-loop process. The envisioned device would save the lives of thousands of military patients each year by effectively treating sepsis and associated complications. See full DARPA-BAA-11-30 attached.

Contact Information

• Agency

  Department of Defense

• Office:

  Defense Advanced Research Projects Agency

• Agency Contact:

  Dr. Timothy Broderick
  DARPA PM

• Agency Mailing Address:

  BAA Coordinator

• Agency Email Address:

  DARPA-BAA-11-30@darpa.mil

• Location:

  DARPA - MTO - BAA0718

• More Information:

  MTO Solicitations page